secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cartesian Therapeutics, Inc. (RNAC)
CIK:        0001453687
Form:       8-K
Filed at:   2025-03-03T23:59:59+00:00
Accession:  0001453687-25-000054
Event type: other_material
Sentiment:  neutral
Materiality: 0.00
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cartesian Therapeutics files 8-K with corporate slide deck; no material news evident
--------------------------------------------------------------------------------

- Slide deck titled 'Pioneering mRNA Cell Therapy for Autoimmunity' dated March 2025 furnished as Exhibit 99.1.
- No financial results, pipeline updates, or guidance changes provided in the filing.
- The exhibit is furnished under Regulation FD and contains no new material information.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453687/000145368725000054/0001453687-25-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453687/000145368725000054/rnac-20250303.htm
  HTML page:      https://secwatch.observer/filing/0001453687-25-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer